Susan Benton

Insider Reports History

Location
Valrico, FL
Signature
/s/ Amy Rabourn, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Benton:

Company Role Class Num Shares Value Price $ Report Date Ownership
Opus Genetics, Inc. Director Common Stock 219,527 $195,379 $0.8900 30 Apr 2025 Direct
Opus Genetics, Inc. Director Stock Option (Right to Buy) 79,592 30 Apr 2025 Direct

Insider Reports Filed by Susan Benton

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IRD Opus Genetics, Inc. 30 Apr 2025 2 $0 4 Director 02 May 2025, 17:04
IRD Ocuphire Pharma, Inc. 11 Jun 2024 2 $0 4 Director 13 Jun 2024, 17:25
IRD Ocuphire Pharma, Inc. 01 Jan 2024 1 $0 4 Director 03 Jan 2024, 17:57
IRD Ocuphire Pharma, Inc. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 18:48
IRD Ocuphire Pharma, Inc. 19 Apr 2023 1 $0 4 Director 21 Apr 2023, 20:20
IRD Ocuphire Pharma, Inc. 11 Jan 2023 1 $0 4 Director 12 Jan 2023, 16:28
IRD Ocuphire Pharma, Inc. 01 Jul 2022 2 $0 4 Director 06 Jul 2022, 18:07
IRD Ocuphire Pharma, Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 16:01
IRD Ocuphire Pharma, Inc. 01 Apr 2022 1 $0 4 Director 05 Apr 2022, 09:16
IRD Ocuphire Pharma, Inc. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 15:01
IRD Ocuphire Pharma, Inc. 01 Oct 2021 1 $0 4 Director 04 Oct 2021, 16:02
IRD Ocuphire Pharma, Inc. 02 Sep 2021 1 +$91,400 4 Director 03 Sep 2021, 16:02
IRD Ocuphire Pharma, Inc. 01 Jul 2021 1 $0 4 Director 02 Jul 2021, 16:02
IRD Ocuphire Pharma, Inc. 07 Jun 2021 1 $0 4 Director 09 Jun 2021, 18:13